I-MED Pharma, a Canadian company specializing in dry eye diagnosis and management, announced that the company has plans to launch its newest, most advanced addition to their I-DROP artificial tear line, called I-DROP MGD.
I-DROP MGD is a premium, preservative-free artificial tear that helps relieve symptoms associated with evaporative dry eye. It is indicated for hydrating and lubricating the cornea. The formulation includes superior osmoprotectants and bioprotectants that stabilize and enhance the lipid layer, while reducing evaporation of the tear film.
I-DROP MGD will offer patients ocular hydration and comfort. It is a long-lasting artificial tear with blink-activated coating and re-coating of the surface of the eye, resulting in increased patient comfort and lower therapy costs to patients, with fewer daily applications required.
Ilan Hofmann, chairman and Chief Scientific Officer of I-MED Pharma, stated, “It is most suited for patients with moderate-to-severe evaporative dry eye disease with a compromised lipid layer. We are very excited to introduce this product to the eyecare community and believe it to be the best solution to offer much-needed relief to these patients.”Back